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Background: GABA has important functions in brain plasticity related processes like memory, learning, locomotion
and during the development of the nervous system. It is synthesized by the glutamic acid decarboxylase (GAD).
There are two isoforms of GAD, GAD1 and GAD2, which are encoded by different genes. During embryonic
development the transcription of GAD1 mRNA is regulated by alternative splicing and several alternative transcripts
were distinguished in human, mouse and rat. Despite the fact that the structure of GAD1 gene has been
extensively studied, knowledge of its exact structural organization, alternative promoter usage and splicing have
remained incomplete.
Results: In the present study we report the identification and characterization of novel GAD1 splicing isoforms
(GenBank: KM102984, KM102985) by analyzing genomic and mRNA sequence data using bioinformatics, cloning
and sequencing. Ten mRNA isoforms are generated from GAD1 gene locus by the combined actions of utilizing
different promoters and alternative splicing of the coding exons. Using RT-PCR we found that GAD1 isoforms share
similar pattern of expression in different mouse tissues and are expressed early during development. Quantitative
RT-PCR was used to investigate the expression of GAD1 isoforms and GAD2 in olfactory bulb, cortex, medial and
lateral striatum, hippocampus and cerebellum of adult mouse. Olfactory bulb showed the highest expression of
GAD1 transcripts. Isoforms 1/2 are the most abundant forms. Their expression is significantly higher in the lateral
compared to the medial striatum. Isoforms 3/4, 5/6, 7/8 and 9/10 are barely detectable in all investigated regions
except of the high expression in olfactory bulb. When comparing GAD1 expression with GAD2 we found that
Isoforms 1/2 are the predominant isoforms. In situ hybridization confirmed the predominant expression of Isoforms
7/8 and 9/10 in the olfactory bulb and revealed their weak expression in hippocampus, cerebellum and some
other areas known to express GAD1.
Conclusions: Generation of ten splicing isoforms of GAD1 was described including two so far uncharacterized
transcripts. GAD1 splicing isoforms producing the shorter, enzymatically inactive GAD25 protein are expressed at
very low level in adult mouse brain except in the olfactory bulb that is associated with neurogenesis and synaptic
plasticity even during adulthood.
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γ-aminobutyric acid (GABA) is the major inhibitory neuro-
transmitter in the adult mammalian central nervous
system. It is a key element in processes like locomotion,
reproduction, learning and is involved as a trophic factor in
the proliferation, migration and differentiation of neurons
during embryonic development [1,2]. GABA is synthesized
from glutamate by the enzyme glutamate decarboxylase
(GAD). GAD exists as two isoforms, GAD1 and GAD2,
having different molecular weights of 67 kDa and 65 kDa,
respectively. They are encoded by separate genes [3-5] and
are coexpressed in most of the GABA-containing neurons,
but often in variable ratios [3,6-9]. GAD isoforms share
enormous sequence homology at protein level, but have dif-
ferent affinity to the cofactor pyridoxal 5′-phosphate and
distinct intracellular localizations, which suggests that they
might be involved in the synthesis of different pools of
GABA with distinct functions [1,4,7,10,11].
Structure, alternative promoters and putative regula-
tory elements of the mouse GAD1 gene were described
previously by Szabo et al. [12] and Yanagawa et al. [13].
The mouse, rat and human GAD1 genes are very similar,
with identical size of exons and conserved splice junction
sites [12-15]. There are increasing evidences for the exist-
ence of transcriptional regulation mechanism for GAD1
gene but not GAD2 gene. During embryonic development
and under some physiological and pathophysiological con-
ditions the transcription of GAD1 mRNA is regulated by
alternative splicing [16-18]. In the course of mouse and
rat embryogenesis, two additional forms of GAD1 were
synthetized by alternative splicing [19-21] encoding
25 kDa leading peptide (GAD25), that corresponds to
the amino-terminal regulatory region of GAD1 and
another enzymatically active form GAD44. In mice and
rats the two additional transcripts are distinguished by
insertion of either 80 or 86 base pairs (bp) into the full-
length GAD1 message upstream of the pyridoxal 5′-
phosphate-binding site [19,20]. These alternatively spliced
exons contain an in-frame overlapping stop/start codon,
thus both alternative transcripts code for a short enzymat-
ically inactive GAD protein of 25 kDa (GAD25). The
shorter 80-bp exon lacks another stop codon at the 3′-
end and termination-reinitiation at the stop/start codon
produces an enzymatically active protein of 44 kDa
(GAD44) corresponding to the carboxyl terminal domain
of GAD1, that contains the pyridoxal 5′-phosphate-
binding site. Alternative splicing of GAD1 gene has been
also described in human pancreatic islet cells, adrenal
cortex and testis. Human alternatively spliced mRNA is
shorter than the GAD1 mRNA and comprises only of the
first seven exons of the human GAD1 gene, thus encoding
a shorter 25-kDa protein [22,23]. In rat testis and other
tissues four novel GAD1 mRNA isoforms synthetized by
alternative splicing combined with the utilization of anintron located polyadenylation site and additional tran-
scription start site located in Intron3 were recently de-
scribed [24,25].
Despite the fact that the structure and regulatory
elements of mouse GAD1 gene have received close atten-
tion in the past decades, knowledge of the exact structural
organization, alternative promoter usage and splicing of
the mouse GAD1 gene have remained incomplete.
Here, we report the identification and characterization of
novel mouse GAD1 mRNA splicing isoforms (GenBank:
KM102984, KM102985) in addition to the previously
described and introduce a new numbering system for the
mouse GAD1 exons. We also report the distinct tissue-
specific expression profiles of the GAD1 splicing isoforms
and the activity of the different promoters in selected
adult mouse brain regions and non-neuronal tissues by
sensitive methods like RT-PCR, quantitative RT-PCR, and
in situ hybridization.Methods
Animals
All experiments were performed in compliance with
the National Institutes of Health Guide for the Care
and Use of Laboratory Animals (NIH Publication No.
80–23, revised 1996) and the Kansai Medical University
local guidelines for animal experimentation (issued 9
March 1999; registration number of the current re-
search proposal, 12–064; permit number, 25–055). This
study had full approval from the Institutional Commit-
tee for Animal Experimentation. All efforts were made
to reduce the number of animals and their suffering.In silico analysis of the structure of mouse GAD1 gene
Mouse GAD1 gene structure in silico analysis was
performed using genomic, mRNA and EST databases
(http://www.ncbi.nlm.nih.gov/). GAD1 mRNA sequence
(GenBank: NM_008077.4) was set to query against the
database collections and high homology was found with
two mouse mRNA sequences (GenBank: AK047521,
AK054554) and one human mRNA sequence (GenBank:
NM_013445.3). These sequences were used for hom-
ology searches and analysis against GAD1 reference
genomic sequence and the sequence of the promoter
region (GenBank: NC_000068.7, Z49978). Multiple
alignment, homology search and ORF prediction were
performed by GENETYX 10.0 (http://www.genetyx.co.jp)
and SIM4 (http://pbil.univ-lyon1.fr/members/duret/cours/
inserm210604/exercise4/sim4.html) for aligning cDNA and
genomic DNA to identify exon and intron regions. Multiple
alignment of amino acid sequences predicted from GAD1
splicing isoforms and analysis of interspecies homologies
were performed with CLUSTALW2 (http://www.ebi.ac.uk/
Tools/clustalw2/index.html).
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different mouse tissues
Total RNA was obtained from the brain of an adult male
C57BL/6J mouse as previously described [9,26,27]. Briefly,
1 μg of total RNA was used for first-strand cDNA synthesis
using 500 ng of oligo(dT) primer (Invitrogen, Life Tech-
nologies, Carlsbad, CA, USA), 500 μM dNTPs (Takara,
Otsu, Japan), 40 units of ribonuclease inhibitor (Toyobo,
Tokyo, Japan), 5 mM DTTand 200 units of SuperScript III
(Invitrogen) in 20 μl of reaction mixture for 10 minutes at
room temperature to allow primer annealing, and then for
1 hour at 50°C. GAD1 isoforms were amplified using com-
mon forward primer in Exon1 (5′-cttcttcaggctctcccgtgc-3′)
or Exon2 (5′-tctcctttttaccctctgcca-3′) and a unique reverse
primer. Isoforms 3, 4, 5 and 6 were amplified in two separ-
ate parts by using forward (5′-gggagtgttggttgctacggtgatg-
3′) and reverse (5′-gtcacactcatgctttggttctgctc-3′) primers
in Exon8 in tandem with the common forward and reverse
(5′-cagctaagcgagtcacagagattggtca-3′) primers for Isoforms
1 and 2. The sequence of the reverse primer used to amp-
lify Isoforms 7 and 8 was: 5′-cagggtccaagagaagtcaaggaagacFigure 1 Sequence of primers used for quantitative RT-PCR, RT-PCR and
acid substitutions in the primers are denoted with red capital letters.c-3′. The reverse primer used to amplify Isoforms 9 and 10
was: 5′-agccagctaggtgatggtca-3′. All isoforms were cloned
in pGEM-T Easy (Promega, Madison, WI) and sequenced
with ABI PRISM BigDye Terminator Cycle Sequencing
Ready Reaction Kits (Applied Biosystems, Tokyo, Japan).
Mouse Multiple Tissue cDNA (MTC) Panel I (Clontech
Laboratories Inc., Mountain View, CA) and cDNAs from
pancreas, small intestine and large intestine (GenoStaff,
Tokyo, Japan) were used as templates to determine the ex-
pression of GAD1 isoforms and GAD2 in different mouse
tissues. The primer pairs used in the RT-PCR analysis are
listed in Figure 1. The PCR mix (25 μl) contained 2.5 μl
template cDNA, 1 μM forward and reverse primers,
200 μM dNTPs (Takara), and 0.5 U Ex Taq HS (Takara).
The number of cycles and the annealing temperature dif-
fered for each isoform and are listed in Figure 1.
Quantitative RT-PCR
Total RNA was obtained from five ten week-old, male
C57BL/6J mice. They were housed under standard condi-
tions with free access to food and water. The animals werepreparation of riboprobes for in situ hybridization. Locked nucleic
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sodium pentobarbital (100 mg⁄kg), and the brains were
rapidly dissected. The olfactory bulb and the cerebellum
were separated primarily. Then coronal sections of 1 mm
thickness were dissected from the cerebrum on an adult
coronal brain matrix (RBMS-200C, Kent Scientific Corp.,
USA) between interaural positions +7.0 mm to +3.8 mm
according to Paxinos and Franklin [28]. Frontal cortex was
taken between cuttings +7.0 mm and +5.5 mm. Medial
striatum and lateral striatum were punched out between
cuttings +5.2 mm and +3.8 mm. The whole hippocampi
were dissected from the rest of the brain. Specimens
were collected in RNAlater (Ambion, Life Technologies,
Carlsbad CA, USA) and kept at −80°C. Total RNA was
purified using RNAqueous-4PCR Kit (Invitrogen) followed
by DNase treatment according to manufacturer’s instruc-
tions. RNA was spectrophotometrically quantified and only
RNA with A260/A280 ratio between 1.8 and 2.1 were
used. 500 ng of total RNA in 20 μl total volume
were reverse transcribed with SuperScript VILO cDNA
Synthesis Kit (Invitrogen). Resulting cDNAs were
stored at −20°C. Primers used for amplification of GAD
transcripts and the reference gene GAPDH (glyceralde-
hyde 3-phosphate dehydrogenase) are listed in Figure 1
and purchased from Invitrogen. To increase the specifi-
city of the primers for Isoforms 1 to 6 and to improve
the discrimination between these highly homologous
sequences the critical nucleotides were substituted with
locked nucleic acids [29,30]. Those primers were pur-
chased from GeneDesign (Osaka, Japan). Quantitative
RT-PCR was carried out on StepOne Real-Time PCR
System (Applied Biosystems) using KOD SYBR qPCR
Mix (Toyobo). The following PCR protocol was ap-
plied: 40 or 45 cycles of 98°C for 10 sec; 62, 63 or 65°C
(primer pair specific; see Figure 1) for 10 sec; 68°C for
30 sec. All samples were run in duplicates and the ana-
lysis was performed on StepOne Software 2.3 (Applied
Biosystems). External standard curves were used for abso-
lute quantification. gBlock Gene Fragments (Integrated
DNA Technologies) were used as standards (Additional
file 1) and the number of transcripts were calculated per
10000 transcripts of GAPDH.
All data are shown as mean ± standard error of the mean
(SEM) of 5 individual animals. Statistical analysis was
performed using GraphPad Prism version 6.00 for Win-
dows (GraphPad Software, San Diego California USA,
www.graphpad.com). One-way ANOVA followed by
Tukey’s post hoc test was used to compare the expres-
sion of: (1) each isoform, Exon1 and Exon2 between
the various mouse brain regions; (2) different isoforms
in one brain region. Differences between Exon1 and
Exon2 expression in each of the investigated brain re-
gions was evaluated by Mann–Whitney U test. P < 0.05
was considered statistically significant.Riboprobe synthesis and in situ hybridization
histochemistry
Total RNA was obtained from an adult male C57BL/6J
mouse and the first-strand synthesis was performed as
described above for the cloning of GAD1 splicing
isoforms. One microliter aliquot of reverse-transcribed
product was amplified by PCR using forward and
reverse primers listed in Figure 1. All fragments were
subcloned into plasmid pGEM-T Easy vector (Promega)
and sequenced with ABI PRISM BigDye Terminator
Cycle Sequencing Ready Reaction Kits (Applied Biosys-
tems). Purified plasmids were linearized and subjected
to in vitro transcription. The reaction was carried out
for 2 hours at 37°C in 20 μl of transcription buffer,
containing 150 ng template DNA, 1 mM GTP, 1 mM
ATP, 1 mM CTP, 0.65 mM UTP, 0.35 mM DIG-11-UTP
(DIG RNA Labeling Mix, Roche Diagnostics, Mannheim,
Germany), 20 units of ribonuclease inhibitor (Toyobo),
and 40 units of T7 (Stratagene, La Jolla, CA) RNA poly-
merase. Riboprobes were precipitated with ethanol and
LiCl, resuspended in diethylpyrocarbonate (DEPC)-treated
dH2O and spectrophotometrically quantitated.
Three digoxigenin-labelled riboprobes were obtained in
antisense and sense strand, namely: (1) Probe-GAD1 –
against 3′-region of Isoforms 1 to 6; (2) Probe-GAD25-
7/8 – against 3′-noncoding region of Isoforms 7 and 8;
(3) Probe-GAD25-9/10 – against the 3′-noncoding re-
gion of Isoforms 9 and 10. Specificity of Probe-GAD1
and its pattern of hybridization in adult mouse brain
are described in details in a previous report [9] and
the probe was used here only for Southern blotting
experiment. Free-floating tissue sections from ten
week-old male C57BL/6J mice were processed for in
situ hybridization as described previously [9,26,27].
Briefly, tissue sections were rinsed in 0.1% DEPC-activated
0.1 M phosphate-buffered saline (pH 7.4) at room
temperature twice for 15 minutes. The sections were then
equilibrated in 5 × SSC (20 × SSC corresponds to 0.3 M
sodium citrate and 3 M sodium chloride, pH 7.0) for
15 minutes and subjected to prehybridization and
hybridization procedures.
Free-floating sections were placed initially into hy-
bridization buffer containing 50% deionized formam-
ide, 40 μg/ml denatured salmon sperm DNA and 5 ×
SSC solution at 55°C for 2 hours. Hybridization was
performed in hybridization mixture with approxi-
mately 1 μg/ml of each digoxigenin-labelled riboprobe
in hybridization buffer at 55°C overnight. Following
this reaction, the sections were rinsed with 2 × SSC
solution at room temperature for 30 minutes; with 2 ×
SSC solution at 65°C for 60 minutes; and three times,
for 20 minutes each time, in 0.1 × SSC solution at
65°C. Digoxigenin-labelled riboprobes were detected
with anti-digoxigenin alkaline phosphatase conjugated
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DIG buffer 1 (0.1 M Tris hydrochloride, 0.15 M so-
dium chloride, pH 7.5) containing 0.5% blocking reagent
(Roche Diagnostics). The chromogenic reaction was car-
ried out in DIG buffer 2 (0.1 M Tris hydrochloride, 0.1 M
sodium chloride, 0.05 M magnesium chloride, pH 9.5)
containing 450 μg/ml nitroblue tetrazolium chloride
(NBT, Roche Diagnostics) and 175 μg/ml 5-bromo-4-
chloro-3-indolyl-phosphate (BCIP, Roche Diagnostics) in
light-protected conditions overnight at 37°C. The enzym-
atic reaction was terminated by rinsing the sections in TE
buffer (10 mM Tris hydrochloride, 1 mM EDTA, pH 8.0)
for 15 minutes. Finally, tissue sections were washed in
0.9% saline solution, mounted on gelatin-coated slides,
dehydrated with successive changes of ethanol (50%, 75%,
95%, 100% and 100% ethanol), clarified in three changes
of xylene and coverslipped with Canada balsam. The
hybridized sections were viewed under a Nikon Eclipse Ni
light microscope (Nikon, Tokyo, Japan) under bright-field
illumination.
Southern blotting
Isoforms 3, 4, 5 and 6 were amplified from mouse adult
cDNA using specific primers. Plasmid containing Iso-
forms 1/2 was used as template in a control reaction and
also to amplify the 3′-region of Isoforms 1 to 6. For all
PCR products, an aliquot of 5 μl was electrophoresed on
1.2% agarose gel with ethidium bromide. The agarose gel
was photographed and processed for Southern blotting
as previously described [31]. The agarose gel was treated
in 0.25 N HCl and 0.4 N NaOH. The PCR-amplified
product was capillary-blotted to Nytran SuPerCharge mem-
brane by TurboBlotter system (GE Healthcare, Amersham,
UK) in a transfer solution of 20 × SSC according to the
manufacturer’s instructions. The membrane was washed in
2 × SSC, and baked at 80°C for 2 hours. Then, it was rinsed
in hybridization buffer comprising 5 × SSC, 2% blocking
reagent (Roche Diagnostics), 0.1% sarcosine, 0.02% SDS
and 50% formamide. The membrane was subjected to
hybridization with Probe-GAD1 – against 3′-region of
Isoforms 1 to 6 (1 μg/ml) in the hybridization buffer
overnight at 55°C. After hybridization, the membrane
was washed with 2 ×, 0.5 × SSC at room temperature,
0.1 × SSC at 55°C for 30 minutes each. Then, the mem-
brane was blocked with 1% blocking reagent in DIG
buffer 1 for 30 minutes. It was incubated with alkaline
phosphatase-labelled anti-digoxigenin antibody (Roche
Diagnostics; 1:500 dilution) for 30 minutes at room
temperature and subsequently washed twice in DIG buffer
1 for 10 minutes. For alkaline phosphatase enzyme
histochemistry, the membrane was incubated with
the reaction mixture containing 450 μg/ml NBT and
175 μg/ml of BCIP in DIG buffer 2 for 30 minutes at
room temperature.Results and discussion
GAD1 gene and mRNA splicing isoforms
The coding region of mouse GAD1 gene comprises 19
exons spanning more than 45 kb of genomic DNA. GAD1
gene is transcribed from multiple promoters positioned
upstream of distinct 5′-noncoding exons. Initially Szabo
et al. [12] described three putative promoter regions (P1,
P2 and P3) just upstream of the first noncoding exon.
Later, Yanagawa et al. [13] revealed the existence of the
fourth liable promoter (P4) between the first noncoding
exon and the first coding exon of GAD1 gene which
results in the transcription of second noncoding exon.
Preferential utilization of the different promoters and
alternative splicing of GAD1 coding and noncoding
exons result in a heterogeneous population of GAD1
mRNAs. Here we present a general scheme of GAD1
gene structure and unified numbering of the noncoding
and coding exons. We also describe the existence of
new coding exons and characterize new alternatively
spliced mRNA isoforms (Figure 2).
In silico analysis of mouse GAD1 gene structure, per-
formed in the present study, revealed two mRNA
sequences (GenBank: AK047521, AK054554) in the
corresponding databases that aligned to the location of
potential novel GAD1 exons. Identification of the
mouse GAD1 transcripts containing novel exons by
RT-PCR, followed by cloning and sequencing con-
firmed the bioinformatics data. Here we describe the
generation of ten mRNA splicing isoforms by the com-
bined action of utilizing different promoters and alter-
native splicing of the coding exons.
Isoform 1 corresponds to the reference mRNA sequence
(GenBank: NM_008077) of GAD1, producing the enzymat-
ically active full length protein GAD67. In this isoform,
Exon1 is alternatively spliced to the common 3′-coding
exon (Exon3). Exon1 together with 64 bp of Exon3 com-
prise the whole 5′-untranslated region of Isoform 1. Exon19
specifies the carboxyl terminal of the protein and also the
entire 3′-untranslated region (Figure 2). Two overlapping
polyadenylation signals (AATAAAATAAA) are located
1191 bp downstream of the TAA translation stop codon
[12-14]. Isoform 2 shares similar structure with Isoform
1 except that it utilizes alternative promoter (P4) and
has Exon2 spliced in front of Exon3 (it lacks Exon1).
The translation initiation codon, stop codon and the
polyadenylation signal are identical to Isoform 1, thus
the same protein is produced. The presence of these
two isoforms in adult mouse brain was confirmed by
nested PCR analysis. The first PCR was performed
using common forward primers in either Exon1 or
Exon2 and a reverse primer at the 3′-end of Isoforms 1
and 2 (Figure 3A). The product of the first PCR was
diluted 500 times and used as a template in a second
PCR reaction with specific primers only for Isoforms 1
GAD1 GENE ORGANIZATION
Isoform 1   (GAD1)
Isoform 3   (GAD25 - 1; GAD44)
Isoform 5   (GAD25 - 1)
2 3 4 5 7 8C
17057301963
1       2 3                 4 5            6/ 6A 7 8A/B/C 9  10/11 12   13   14 15  16           17         18   19
1 3 4 5 6A
3548911234
1 3 4 5 6 7 9 1110 12 13 14 15 16 17 18 19
3231234 2012
1 3 4 5 6 7 8C
234 1570902
Isoform 2   (GAD1)
2 3 4 5 6 7 9 1110 12 13 14 15 16 17 18 19
3366369 2147
1 3 4 5 6 7 8A 1110 12 13 14 15 16 17 18 199
234 3311 2092902 
Isoform 4   (GAD25 - 1; GAD44)
2 3 4 5 6 7 8A 1110 12 13 14 15 16 17 18 199
369 344622271037
1 3 4 5 6 7 8B 1110 12 13 14 15 17 18
234 3317 902
169 19
Isoform 6   (GAD25 - 1)
2 3 4 5 6 7 8B 1110 12 13 14 15 17 18
369 34521037
169 19
Isoform 7   (GAD25 - 1)
Isoform 8   (GAD25 - 1)
Isoform 9  (GAD25 - 2)
Isoform 10  (GAD25 - 2)
2 3 4 5 6A
36831046369
  6
Figure 2 Exon/intron structure and alternative mRNA transcripts of mouse GAD1 gene. The new arrangement of mouse GAD1 exons and
introns as determined after the analysis of genomic and cDNA sequence data using bioinformatics, 3′-RACE, RT-PCR, cloning and sequencing. Exons
are shown as numbered boxes (red numbers represent alternatively spliced exons) and introns as lines. Large boxes indicate the coding DNA sequence
and the small boxes the 5′- and 3′-untranslated regions. The red arrowheads are showing the locations of the alternative promoters. The schematic
representation of GAD1 splicing isoforms in relation to the gene is shown below the gene structure. The length in base pairs and the position of start
and stop codons are indicated above each isoform. Diagrams are not to scale.
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Exon2 in combination with a primer close to the polya-
denylation sequence the isoforms were cloned and their
sequences verified by sequencing.
Isoform 3 contains Exon1 and Exon8A which is 80 bp
long (Figure 2). This exon was first described in embry-
onic rat brain [20] and then its existence was confirmed
in the mouse [19]. Isoform 4 shares the same structureexcept that it has Exon2 and is produced by utilizing the
alternative promoter P4. Exon8A contains an overlap-
ping stop/start codon (TGATG) which divides the open
reading frame (ORF) of GAD1 in two overlapping ORFs.
The first is coding for a 25 kDa leading peptide (GAD25-1)
and the second one for a 44 kDa enzymatically active
peptide (GAD44). To precisely localize the polyadenylation
signal of these two isoforms, 3′-RACE was employed (data
C           brain             plasmid Isoform 1/2
 Ma      Is-5/6   Is-3/4   Is-5/6   Is-3/4   Is-1/2
D
A
         Is-1/3/5  Is-2/4/6
Ma   Exon1 Exon2   Is-7    Is-8    Is-9    Is-10
B
 Ma      Is-1    Is-2    Is-3   Is-4     Is-5    Is-6
Figure 3 Expression analysis of mouse GAD1 splicing isoforms in adult brain. (A) RT-PCR analysis of the expression of GAD1 mRNA splicing
isoforms in adult mouse brain by using a forward primer either in Exon1 or Exon2 and a specific reverse primer for each transcript. (B) Analysis of
the expression of Isoforms 1 to 6 by using the PCR product of lanes Exon1 and Exon2 in (A) as template for nested PCR with specific primers for
each isoform. (C) Gel electrophoresis of Isoforms 3/4 and 5/6, amplified from mouse brain cDNA using specific forward primer and reverse primer,
close to the position of the polyadenylation signal. Plasmid containing Isoforms 1/2 was used as a negative control with the primers for Isoforms
3/4 and 5/6 and as a positive control with primers amplifying the 3′-end of Isoforms 1/2. (D) Southern blotting of the gel in (C). The membrane
was probed with Probe-GAD1 against 3′-region of Isoforms 1 and 2. Ma, marker λ/HindIII-ϕX174/HaeIII.
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same polyadenylation signal as Isoforms 1 and 2, at least in
adult mouse brain. This is in conflict with the previously
described length of about 2000 bp of these transcripts de-
tected on Northern blots [12]. To further verify the position
of the polyadenylation signal and the length of these
isoforms, they were amplified from adult mouse brain by
specific forward primer and reverse primer in the vicinity
of the polyadenylation signal of Isoforms 1 and 2. Plasmid
containing Isoforms 1 and 2 was used as negative con-
trol to check for the co-amplification of this variants
due to the great sequence similarity; and also as a posi-
tive control to amplify the 3′-end of Isoforms 1 and 2
(Figure 3C). Single band with the expected length was
detected in the brain and no co-amplification was
visible. Then the bands were blotted on a nylon mem-
brane and probed with Probe-GAD1 against 3′-region
of Isoforms 1 and 2. The band of Isoforms 3 and 4 was
clearly labelled together with the control band (Figure 3D).
The presence of Isoforms 3 and 4 in adult mouse brain
was also confirmed by nested PCR analysis (Figure 3A
and B) and the fragments were cloned and the exactsequence verified by sequencing. These results combined
with the 3′-RACE data confirmed that Isoforms 3 and 4
were utilizing the same polyadenylation signal as Isoforms
1 and 2 in adult mouse brain.
Isoform 5 contains Exon1 and Exon8B which is 86 bp
long (Figure 2). It differs from Exon8A by the presence
of 6-bp insert at the 3′-end. Isoform 6 shares the same
structure except that it has Exon2. This insert contains a
downstream TGA translation stop codon that interrupts
the ORF of GAD44 initiating at the overlapping TGATG
codon. Thus Isoforms 5 and 6 code only for the shorter
GAD25-1 protein. To find out whether these isoforms
share the same polyadenylation signal as Isoforms 1, 2, 3
and 4 we performed 3′-RACE analysis (data not shown)
and also PCR analysis identical to the one described for the
previous two isoforms. PCR amplification revealed single
band with the expected size and no co-amplification with
Isoforms 1 and 2. Moreover, after the Southern blot
hybridization the probe specific for the 3′-region of Iso-
forms 1 and 2 clearly labelled the band of Isoforms 5 and 6
(Figure 3C and D). The fragments were also cloned and
sequenced to verify the correct sequence. The expression
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nested PCR using specific primers (Figure 3A and B).
Isoform 8 contains Exon2, Exon8C and corresponds to a
sequence in the GenBank database (GenBank: AK047521).
This sequence is 1705 bp long, the translation initiation
site is the same as in previous isoforms and the stop codon
is located 666 bp downstream of the ATG codon in
Exon8C. Exon8C is identical to the Exon8B until its 3′-
splice site and then becomes homologous to the gen-
omic GAD1 sequence (GenBank: NC_000068.7). Then
it encodes two overlapping polyadenylation signals (AA
TAAAATAAA) located 647 bp downstream of the TGA
translation stop codon. This variant was amplified from
adult mouse brain cDNA, cloned and sequenced
(Figure 3A). To identify the predicted splice variant
containing Exon1 instead of Exon2, PCR was employed
using primers listed in Figure 1. Transcript with a
length of 1570 bp, which will be referred as Isoform 7
(Figure 2), was isolated (Figure 3A), cloned and its
sequence verified by sequencing and deposited into
GenBank (GenBank: KM102984). These isoforms are
coding for the shorter GAD25-1 leading peptide. Simi-
lar short transcripts were identified in human adult and
fetal pancreatic islet cells, testis and adrenal gland
[22,23,32]. The length of these two isoforms is almost
identical to the length of the mRNA transcripts detected
by Szabo et al. [19] on Northern blots. They assumed that
the short length of the transcripts (corresponding to Iso-
forms 3, 4, 5 and 6) is due to the utilization of unconven-
tional putative polyadenylation signal (AATAAT) 171 bp
downstream from the translation termination codon [12].
According to our data probably these short mRNAs are
corresponding to the Isoforms 7 and 8. Moreover, these
two isoforms appear to be also more abundantly expressed
than Isoforms 3, 4, 5 and 6, at least in adult mouse brain.
Utilization of different polyadenylation signals in embry-
onic versus adult mouse brain for the same isoforms
might be another feasible explanation for this discrepancy.
Isoform 9 contains Exon1 and Exon6A (Figure 2), and
with the exclusion of few sequencing inaccuracies (at
position 1616 CT is present; at position 1647 there are
two unnecessary CC bases) it corresponds to a cDNA se-
quence in the GenBank database (GenBank: AK054554).
We have identified another isoform, referred here as Iso-
form 10 (Figures 2 and 3A) by PCR, cloning and sequen-
cing. Its sequence was deposited to GenBank (GenBank:
KM102985). This isoform shares the same sequence as
Isoform 9, except the utilization of different promoter and
the presence of Exon2. The TGA termination codon is
located in Exon6A, 675 bp downstream from translation
initiation codon. In the so far cloned and confirmed se-
quences of Isoforms 9 and 10 we were not able to identify
possible polyadenylation signals, and the 3′-RACE pro-
duced inconclusive results (data not shown).Isoforms 3 to 10 are encoding the translation of the
protein GAD25 corresponding to the putative regulatory
region of the full length GAD1. Isoforms 3 to 8 share the
same ORF and are producing identical GAD25-1 protein
of 223 amino acids. Isoforms 9 and 10 have ORFs that
differ at the 3′-end and probably are translated into
GAD25-2 protein of 226 amino acids. The last 11 amino
acids of GAD25-1 and 44 amino acids of GAD25-2 are
unique to these proteins, because they are derived from
the alternatively spliced exons. Of note is that, the carb-
oxyl terminal 11 amino acids (where GAD25-1 diverges
from GAD1) are identical in human [22] (GenBank:
NP_038473) and mouse (Figure 4).
Alternative promoters, splicing and polyadenylation
of genes during embryogenesis and adulthood can lead
to the synthesis of new isoforms derived from one gene.
These lead to the diversity of gene expression and in
the translated proteins. Our data reveal that Isoforms 3
to 10 are predicted to be translated into truncated
GAD25 proteins. The functional significance of these
GAD25 proteins in normal embryonic and adult brains,
and in pathophysiological conditions is still unclear. It
might be implied that the generation of these tran-
scripts is more likely to regulate GAD1 gene expression
and the level of GAD activity [18,24,25,33].
Expression of GAD1 isoforms and GAD2 in different
mouse tissues
Using Mouse MTC Panel I as cDNA template and cDNAs
from pancreas, small intestine and large intestine we
examined the expression levels of different GAD1 mRNA
isoforms and GAD2 (Figure 5). The different primer sets
and specific PCR conditions for each isoform are listed in
Figure 1. Isoforms 1, 2, 3, 4, 5 and 6 share great sequence
similarities. Control PCR reaction was performed to adjust
the appropriate conditions for each primer pair and to
verify their specificity. In the control reaction primer pairs
for Isoforms 1/2, 3/4 and 5/6 were tested with plasmids
containing each full length insert as a template. Under the
specified conditions each primer pair was able to amplify
only the dedicated isoform without any co-amplification
(Figure 5G).
Isoforms 1/2 were detectable at high level in brain,
kidney, testis and during all embryonic days; low level of
expression was detectable in spleen, lung, pancreas, small
intestine, large intestine and the lowest level in heart and
skeletal muscle (Figure 5A). The tissue pattern of ex-
pression of Isoforms 3/4, 5/6, 7/8 and 9/10 was similar
to that of the Isoforms 1/2 (Figure 5C-F). The highest
expression of these variants was during all embryonic
days included in the MTC panel I and in the adult
brain; low expression level was detected in spleen,
pancreas, small intestine and large intestine; and no
expression was detected in the heart. Isoforms 3/4 were
Figure 4 The alignment of amino acid sequences of human and mouse GAD25. GAD25-1 protein of 223 amino acids is produced by Isoforms
3 to 8. GAD25-2 protein of 226 amino acids is produce by Isoforms 9 and 10. The last 11 amino acids (marked in orange) of GAD25-1 and 44 amino
acids (marked in yellow) of GAD25-2 are unique to these proteins. * (asterisk) indicates positions which have a single, fully conserved residue;
: (colon) indicates conservation between amino acids of strongly similar properties; . (period) indicates conservation between amino acids of weakly
similar properties.
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http://www.biomedcentral.com/1471-2202/15/114not detectable in testis; Isoforms 5/6 were not detect-
able in skeletal muscle; and Isoforms 9/10 could not be
detected in lung and kidney. GAD2 in contrast was
highly expressed only in brain, large intestine and dur-
ing 11th, 15th and 17th embryonic days; low expres-
sion was detected in kidney, testis and small intestine
(Figure 5B).
The expression pattern of Isoforms 1/2 in the brain
and non-neural tissues is similar to the previously
reported results [34,35]. GAD1 but not GAD2 is highly
expressed in pancreatic islet cell of the mouse [36-38].
In contrast human and monkey islet cells produce only
GAD2. Also in accordance with previous data [12,20,21,33]
GAD1 isoforms were moderately expressed even at the 7th
embryonic day, while GAD2 became detectable later, at the
11th embryonic day.Quantitative RT-PCR analysis of the expression of GAD1
isoforms and GAD2 in different areas of adult mouse
brain
The present study shows the expression level and
expression pattern of GAD1 mRNA splicing isoforms
and GAD2 in defined regions of the adult mouse
brain. Expression of GAD2 was similar in frontal cor-
tex, hippocampus and cerebellum. The highest level of
expression was in the striatum followed by the olfac-
tory bulb. The expression in medial striatum was
significantly higher compared to all studied regions
except olfactory bulb and lateral striatum (Figure 6;
Additional file 2). These findings are in correlation
with our previous results from in situ hybridization
study of the expression of GAD1 and GAD2 in adult
mouse striatum [9].





Isoform 1/2   Isoform 5/6  Isoform 3/4
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Figure 5 Expression of GAD1 mRNA splicing isoforms and GAD2 in different mouse tissues and during development. The expression
level of Isoforms 1/2 (A), GAD2 (B), Isoforms 3/4 (C), Isoforms 5/6 (D), Isoforms 7/8 (E), Isoforms 9/10 (F) are compared by PCR amplification using
mouse Multiple Tissue cDNA Panel I and cDNA from pancreas, small intestine, and large intestine as cDNA template. (G) Control PCR reaction to
verify the specificity of the primers for Isoforms 1/2, 3/4 and 5/6. In the control reaction each primer pair was tested with a plasmid containing
each full length insert as a template. The template in lanes 1, 4 and 7 was plasmid containing Isoforms 1/2 as template; lanes 2, 5 and 8, plasmid
containing Isoforms 5/6; and lanes 3, 6, 9 plasmid containing Isoforms 3/4. Lanes (Ht) heart; (Br) brain; (Sp) spleen; (L) lung; (Li) liver; (Ms)
muscle; (K) kidney; (Ts) testis; (E7) 7-day embryo; (E11) 11-day embryo; (E15) 15-day embryo; (E17) 17-day embryo; (P) pancreas; (SI) small
intestine; (LI) large intestine; (N) no template control; (−) plasmid containing Isoforms 1/2 is used as template for the amplification; and Ma,
marker ϕX174/HaeIII.
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GAD1 enzyme and referred in the literature as adult
isoforms was highest in olfactory bulb, followed by the
striatum. In the lateral striatum the expression of Isoforms
1/2 was 1.3 folds higher than in the medial striatum. This
is similar to the results from our previous study [9] show-
ing the difference in the expression level of GAD1 in
lateral versus medial striatum. In this in situ hybridization
study we found about 1.5 folds difference in the relative
expression levels of GAD1 in the lateral compared to the
medial striatum. Level of expression in frontal cortex and
hippocampus was almost equal and the lowest compared
to the other examined regions (Figure 6; Additional file 2).
When comparing the adult GAD1 message with GAD2
we found that Isoforms 1/2 are the predominant isoforms
in all studied regions except the medial striatum where no
significant difference in the expression level was observed
(Figure 6; Additional file 2). In accordance to our results,
in situ hybridization and immunohistochemical studies in
adult rats clearly showed a stronger labelling for GAD1
compared to GAD2 in most of the studied regions [3,6-8].
In contrast, Popp et al. [39] found that in the rat GAD2
mRNA was predominant in the hippocampus, and in allother regions there were not any prevalence of one of the
adult GAD forms, but probably this discrepancy comes
from different species that were used.
Isoforms 3/4 and 5/6, that are referred in the literature
as embryonic isoforms, because of their high expression
during early embryogenesis [1,19-21], were barely de-
tectable in frontal cortex, hippocampus and cerebellum.
The olfactory bulb showed the highest transcript level
followed by the striatum. There were no significant differ-
ences in the expression level of these isoforms between
the lateral and medial striatum (Figure 6; Additional
file 2). Comparison between the expression of Isoforms
3/4 and 5/6 revealed that in the olfactory bulb there were
about 4 times more Isoforms 5/6 than Isoforms 3/4. In
cerebellum the ratio was 7 times higher in favor of Iso-
forms 5/6. The prevalence of Isoforms 5/6 coincides with a
previous quantitative RT-PCR study in the rat [39]. In
contrast Szabo et al. [19] reported that Isoforms 5/6 were
only expressed in early developmental stages (E10.5-
E11.5) and were not detectable in adult brain, whereas Iso-
forms 3/4 were more abundant in later embryonic stages
and low level is detectable in adult brain. Probably the
higher sensitivity of the quantitative RT-PCR compared to
Figure 6 Expression of GAD1 mRNA splicing isoforms and GAD2 in olfactory bulb, frontal cortex, medial striatum, lateral striatum,
hippocampus and cerebellum of adult mouse brain. Samples were examined for GAD transcripts by quantitative RT-PCR. Number of transcripts
were calculated per 10000 transcripts of GAPDH. Data is presented as mean ± SEM of five individual animals and analyzed by one-way ANOVA
followed by Tukey’s post hoc test. ** P≤ 0.0001, * P < 0.05. (CpuM) medial striatum; (CpuL) lateral striatum.
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http://www.biomedcentral.com/1471-2202/15/114the RT-PCR is responsible for this discrepancy, but our
RT-PCR data also implicates higher level of expression of
Isoforms 5/6 in adult brain (Figure 5C and D).
Predominant expression of Isoforms 7/8 and 9/10 was
in the olfactory bulb, similar to the previously described
Isoforms 3/4 and 5/6. They showed similar low level of
expression in frontal cortex, hippocampus and cerebel-
lum. The expression in the striatum was moderate and
there was not statistically significant difference between
the levels in lateral and medial striatum (Figure 6;
Additional file 2). Of all embryonic GAD1 mRNAs, Iso-
forms 7/8 appear to be the most abundant forms in adult
mouse brain. They are significantly higher than Isoforms
3/4, 5/6 and 9/10 in olfactory bulb, frontal cortex and
medial striatum; and additionally in cerebellum com-
pared to Isoforms 9/10.
Expression of the two alternatively spliced 5′-noncoding
exons was analyzed in the studied brain regions in an
attempt to investigate the level of activity of the different
promoters (Figure 7; Additional file 2). Expression pattern
of the two transcripts was similar to that of Isoforms 1/2.
The number of transcripts was similar in frontal cortex,
hippocampus and cerebellum. The highest level of expres-
sion was in olfactory bulb, followed by the striatum.
Significant difference in the expression in lateral striatum
compered to medial striatum was demonstrated only for
Exon2. Comparing the expressions of each exon revealed
that Exon1 is the predominant form in all regions. These
results closely resemble the findings of Yanagawa et al.[13] that have found by RT-PCR the abundance of Exon1
in the mouse brain. It might be concluded that promoter
P1, that resembles the promoters of housekeeping genes
and minor promoters P2 and P3 [12] are preferentially
activated in the adult mouse brain.
In situ hybridization for GAD1 Isoforms 7/8 and Isoforms
9/10 in adult mouse brain
Using specific digoxigenin-labelled riboprobes located
in the unique 3′-noncoding region of Isoforms 7/8 and
9/10 we investigated their expression in the adult
mouse brain. Because of the enormous sequence hom-
ology between the other GAD1 isoforms it is impossible
to prepare digoxigenin-labelled riboprobes with enough
specificity. The level of expression of Isoforms 7/8 and
9/10 was low, but resembled closely the expression of
GAD1 as reported in the rat and mice [6-9]. The high-
est expression of Isoforms 7/8, revealed by quantitative
RT-PCR, in olfactory bulb could be confirmed by non-
radioactive in situ hybridization (Figure 8A). The cells
of the granule cell layer were intensely labelled and
moderate labelling was detectable in the glomerular cell
layer and in the accessory olfactory bulb. In frontal cortex
and other cortical areas there was moderate expression of
Isoforms 7/8 in numerous inhibitory interneurons. Strong
labelling could be seen in the cell of olfactory tubercle,
while the staining in the ventral pallidum was moderate
(Figure 8B and D). Low expression could be demonstrated
in the striatum and accumbens nucleus (Figure 8B and D).
Figure 7 Expression of Exon1 and Exon2 in olfactory bulb, frontal cortex, medial striatum, lateral striatum, hippocampus and
cerebellum of adult mouse brain. Samples were examined for Exon1 and Exon2 transcripts by quantitative RT-PCR. Number of transcripts were
calculated per 10000 transcripts of GAPDH. Data are presented as mean ± SEM of five individual animals. Expression of Exon1 and Exon2 in each
of the investigated brain regions was evaluated by Mann–Whitney U test. # P < 0.05. Comparison of the expression of Exon1 and Exon2 between
the various mouse brain regions was analyzed by one-way ANOVA followed by Tukey’s post hoc test. * P < 0.05. (CpuM) medial striatum; (CpuL)
lateral striatum.
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http://www.biomedcentral.com/1471-2202/15/114In the diencephalon, strong labelling was visible in the
suprachiasmatic nucleus (Figure 8E) and arcuate
nucleus (Figure 8F), while in the ventromedial hypo-
thalamus (Figure 8F) and the reticular nucleus of the
thalamus (Figure 8E) it was weaker. In the hippocam-
pus many inhibitory interneurons were strongly labelled
for Isoforms 7/8 (Figure 8G). The most intense labelling
was in the granule cells of the dentate gyrus, followed
by the cells in the pyramidal layer of CA3 region and
some cells in the hilar region. GAD1 mRNA and immu-
noreactivity have been described in the granule cells
and their mossy fibers which represent the major gluta-
matergic pathway of the hippocampus. Markedly increased
expression of adult GAD1 and so called embryonic GAD1
variants (Isoforms 1 to 6) was demonstrated in adult
models of epilepsy by in situ hybridization, immunohisto-
chemistry and RT-PCR [40,41]. Using radioactive in situ
hybridization with an oligonucleotide probe Szabo et al.
[12] detected trace amounts of embryonic GAD1 variants
in the granule cells of rat dentate gyrus, which was mark-
edly enhanced after kainic acid induced seizures. Theprobe used in that experiment was specific to Exon8 and
could label Isoforms 3, 4, 5, 6, 7 and 8 described here.
Specific labelling for Isoforms 7/8, distinguishable from
the background, could not be detected in the brain-
stem. In the cerebellum strong labelling was visible in
the Purkinje cells, and moderate to low labelling in the
molecular and granular cell layers (Figure 8C). Radio-
active in situ hybridization studies using oligonucleotide
probe in the vicinity of Exon8 (recognizing Isoforms 3/4,
5/6 and 7/8) have described sequential expression of
embryonic and adult GAD1 transcripts [21,39]. In areas
like olfactory bulb with high level of cell proliferation and
migration embryonic variants are more abundant.
The level of expression of Isoforms 9/10 was significantly
lower than Isoforms 7/8. Strong labelling was seen in the
olfactory bulb (Figure 8H). Also, some interneurons of the
dentate gyrus, CA and the hilus of the hippocampus
were moderately labelled (Figure 8I). In the cerebellum
the labelling was intense in the Purkinje cells, and very




































Figure 8 Expression of GAD1 Isoforms 7/8 and Isoforms 9/10 in adult mouse brain detected by in situ hybridization. Expression of
Isoforms 7/8 (A-G) and expression of Isoforms 9/10 (H-J). Moderate expression of Isoforms 7/8 was detected in olfactory bulb (A). Low expression was
detectable in olfactory tubercle and accumbens nucleus (B); cerebellum (C); lateral septal nucleus, ventral pallidum and striatum (D); suprachiasmatic
nucleus (E); VMH and arcuate nucleus (F); hippocampus (G). Expression of Isoforms 9/10 could be detected only in olfactory bulb (H), hippocampus
(I) and cerebellum (J). Acb, accumbens nucleus; aca, anterior commissure; AOB, accessory olfactory bulb; Arc, arcuate nucleus; Cpu, caudate putamen
(striatum); cc, corpus callosum; DG, dentate gyrus; EPl, external plexiform layer of olfactory bulb; FrA, frontal association cortex; Gl, glomerular layer of
olfactory bulb; GrO, granular cell layer of olfactory bulb; Gr, granular cell layer of cerebellum; LS, lateral septal nucleus; Mi, mitral cell layer of olfactory
bulb; Mo, molecular cell layer of the cerebellum; P, Purkinje cells; Rt, reticular nucleus; Sch, suprachiasmatic nucleus; Tu, olfactory tubercle; VMH,
ventromedial hypothalamic nucleus; VP, ventral pallidum. Scale bar = 100 μm (J), 200 μm (B, C, E, F and I), 300 μm (A, G and H). Scale bar = 1 mm (D).
Trifonov et al. BMC Neuroscience 2014, 15:114 Page 13 of 15
http://www.biomedcentral.com/1471-2202/15/114Conclusions
In summary, GAD1 gene in mouse brain is extensively
regulated at the level of transcription. So far ten alter-
natively spliced isoforms were identified, which are
produced by combined action of different promoter
utilization and splicing of coding exons. Isoform 1 and
Isoform 2 are translated into the full length, enzymati-
cally active GAD1 protein with 67 kDa molecular
weight. Isoforms 3 to 10 are responsible for the produc-
tion of a short, enzymatically inactive peptide with
unknown function and molecular weight of 25 kDa
(GAD25-1 and GAD25-2). GAD25 is highly conserved
between human and mouse. Isoforms 3 and 4 are capa-
ble of producing a second 44 kDa peptide with enzyme
activity (GAD44). All alternatively spliced isoforms
share similar pattern of expression in different mouse
tissues. The highest level of expression in the brain is
in the olfactory bulb, followed by the striatum. Themost abundant isoforms in the adult brain are Isoforms
1 and 2. The isoforms producing GAD25 are barely de-
tectable in the adult mouse brain with the exception of
the comparatively high expression in the olfactory bulb.
This predominant localization in the olfactory bulb was
confirmed for Isoforms 7/8 and 9/10 by in situ hybri-
dization. The low expression of the isoforms respon-
sible for the synthesis of GAD25 implies its limited
relevance in postnatal development, but their signifi-
cantly higher expression in areas associated with neuro-
genesis and high synaptic plasticity like olfactory bulb
and hippocampus, suggests their functional role in the
proliferation and maturation of neuroblasts, synapto-
genesis and synaptic plasticity. The detailed description
of GAD1 splicing isoforms could be useful for further
studies on the regulation of GAD1 expression during
nervous system development and plasticity, and also dur-
ing certain pathological conditions.
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